Electromed, Inc. (ELMD) Stock Price & Analysis
Electromed, Inc. (ELMD) fell 2.13% to USD 36.29 as of June 10, 2026 at 07:01 UTC, according to Nexqual real-time market data.
ELMD last closed at USD 37.08; the session ranged USD 36–37.49 on volume of 41,133 shares. Market capitalization is $300.48M, with a 52-week range of USD 17.73–40 (ASE). Source: Nexqual, June 10, 2026 at 07:01 UTC.
Key Statistics (as of June 10, 2026 at 07:01 UTC)
| Price | USD 36.29 |
|---|---|
| Change | ▼ 2.13% (down) |
| Previous Close | USD 37.08 |
| Open | USD 36.6 |
| Day Range | USD 36 – 37.49 |
| 52-Week Range | USD 17.73 – 40 |
| Volume | 41,133 shares |
| Market Cap | $300.48M |
| Exchange | ASE |
Technical Analysis (ELMD)
Nexqual's technical model rates ELMD "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 07:01 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 62.82 (neutral) |
| vs SMA50 | Above (USD 29.58) |
| MACD | 2.29 (positive) |
Analyst Ratings (ELMD)
Wall Street analysts rate ELMD "None" based on 3 analysts, with a mean price target of USD 40.33 (range USD 36–45), per Nexqual as of June 10, 2026 at 07:01 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 40.33 |
| High Target | USD 45 |
| Low Target | USD 36 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (ELMD)
| Next Earnings Date | 2026-05-12 |
|---|---|
| Revenue Estimate | $19.33M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD 0.32 vs est 0.26 ▲ beat |
| 2025-09-30 | USD 0.25 vs est 0.21 ▲ beat |
| 2025-06-30 | USD 0.25 vs est 0.22 ▲ beat |
Source: Nexqual, June 10, 2026 at 07:01 UTC.
Financials & Fundamentals (ELMD)
| Total Revenue | $71.75M |
|---|---|
| Revenue Growth (YoY) | +18.40% |
| Gross Margin | +78.44% |
| Operating Margin | +20.28% |
| Profit Margin | +14.08% |
| ROE | +21.70% |
| Debt / Equity | 0.17 |
| Current Ratio | 4.91 |
| Total Cash | $16.98M |
| Total Debt | $81,000 |
| Free Cash Flow | $8.32M |
Source: Nexqual, June 10, 2026 at 07:01 UTC.
Financial Health Score (ELMD)
Nexqual rates Electromed, Inc.'s overall financial health "Strong" across five dimensions, as of June 10, 2026 at 07:01 UTC.
| Growth | Strong — Revenue +17% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 78%, operating 20% |
| Balance Sheet | Strong — $17M cash, no debt |
| Cash Flow | Solid — FCF $8M, 13% margin |
| Efficiency | Strong — ROE 22%, ROA 14.9% |
Ownership (ELMD)
| Insider Ownership | +21.44% |
|---|---|
| Institutional Ownership | +59.07% |
| Shares Outstanding | 8.28M |
| Float | 6.47M |
| Short % of Float | +2.04% |
Source: Nexqual, June 10, 2026 at 07:01 UTC.
Leadership (ELMD)
Electromed, Inc. is led by James L. Cunniff (age 59), President, CEO & Director, per Nexqual as of June 10, 2026 at 07:01 UTC.
| President, CEO & Director | James L. Cunniff (age 59) |
|---|---|
| CFO, Treasurer & Secretary | Bradley M. Nagel (age 43) |
Major Backers & Investors (ELMD)
Notable institutional backers of Electromed, Inc. include J.e. Simmons & Co., P.c., Punch & Associates Investment Management, Inc., Acadian Asset Management. LLC, according to Nexqual as of June 10, 2026 at 07:01 UTC.
Active Investors
| Investor | Stake |
|---|---|
| J.e. Simmons & Co., P.c. | 5.95% |
| Punch & Associates Investment Management, Inc. | 2.71% |
| Acadian Asset Management. LLC | 2.69% |
| Two Sigma Investments, LP | 2.46% |
| Hunter Associates Investment Management LLC | 1.82% |
| Gamco Investors, Inc ET AL | 1.71% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 8.46% |
| BlackRock | 8.05% |
| Geode Capital | 2.44% |
| Dimensional Fund Advisors | 2.15% |
Source: Nexqual, June 10, 2026 at 07:01 UTC.
From Electromed, Inc.'s Latest SEC 10-K Filing (filed 2025-08-26)
Key Strengths & Strategy (as disclosed to the SEC)
- Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
- It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting.
- It markets its products to physicians, health care providers, and directly to patients.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INFU | InfuSystems Holdings, Inc. | USD 9.01 | ▼ 2.49% |
| PDEX | Pro-Dex, Inc. | USD 65 | ▼ 0.32% |
| DLHC | DLH Holdings Corp. | USD 5.56 | ▼ 0.36% |
| IRMD | iRadimed Corporation | USD 96.42 | ▲ 3.6% |
| EVI | EVI Industries, Inc. | USD 17.16 | ▼ 2.67% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:01 UTC. This page is informational and not investment advice.